A Study Has Revealed The Biggest Risk Factors For Getting Early Dementia, And Knowledge Is Power
The data analyzed the behaviors of over 350,000 participants younger than 65 across the United Kingdom to evaluate young-onset dementia, which occurs before age 65. The researchers found there are 15 common issues that can contribute to the early development of the condition. A few have to do with genetics and other elements outside our control, but many others are modifiable.
The study is meaningful to experts because it 'looks at young-onset dementia risk factors in a way that has only been done in late-onset dementias previously,' according to Dr. Kevin Bickart, an assistant professor in neurology at the University of California Los Angeles Health's David Geffen School of Medicine. The study features 'a very large sample that was prospectively followed from healthy baseline to a dementia diagnosis with lots of data collection.'
Here's what to know:
The biggest risk factors for young-onset dementia:
Related: "This Has Taken Me Years And Years And YEARS To Figure Out": This Woman's Clever Way To Tell If Someone Is Your Real Friend Is Being Called The Most Accurate Thing Ever
Related: 25 Eye-Opening Confessions From A Trauma Therapist That Changed The Way I Think About Mental Health
The large-scale study looked at 39 possible risk factors and determined that 15 of them made the biggest difference when it came to developing dementia before the age of 65. Those include:
Social isolation
Lower formal education
Lower socioeconomic status
Carrying two copies of the APOE gene (a marker that influences Alzheimer's risk)
Vitamin D deficiency
Hearing impairment
Alcohol use disorder
No alcohol use (abstinence)
Depression
High C-reactive protein levels
Lower handgrip strength (physical frailty)
Orthostatic hypotension (a form of low blood pressure)
Stroke
Diabetes
Heart disease
Although some recognized risks are out of many people's control ― like being a carrier of the APOE gene or your socioeconomic status ― others can be managed through lifestyle changes.
What you can do to lower your risk of early-onset dementia.
Overall, the study results are consistent with what medical experts have been advising patients for years.
Dr. Arman Fesharaki-Zadeh, an assistant professor of psychiatry and of neurology at the Yale School of Medicine, recommended three 'lifestyle measures' that folks may want to consider when trying to lower their risk of young-onset dementia ― starting with physical exercise.
'An active daily exercise practice can have far-reaching benefits, which include enhanced neurocognitive function,' Fesharaki-Zadeh said, adding that physical activity can boost neurogenesis (the formation of new neurons and synapses), vasculogenesis (the creation of new blood vessels) while also providing inherent mood benefits.
Next, focus on eating nourishing foods. Fesharaki-Zadeh championed a Mediterranean-based diet, mentioning its well-documented benefits.
'Such dietary practice, which includes food groups such as green leafy vegetables, olive oil, salmon and blueberries, is rich in vitamins, omega-3 fatty acids, as well as antioxidants ― all neuroprotective factors,' he explained.
Fesharaki-Zadeh recommended cognitive, mood and social stimulation to keep your mind sharp.
For cognitive stimulation, this could look like learning a new language or attending a seminar, listening to music or dancing. Basically, anything that engages your mind will help it stay healthy. Mood stimulation, on the other hand, relates to stress reduction practices, 'such as mindfulness and yoga,' Fesharaki-Zadeh said.
As for social stimulation, it's pretty simple: Try to connect with other humans face-to-face and actually talk to them as much as possible. 'In the era of pandemic and now post-pandemic, quality social connections should increasingly be encouraged and practiced,' Fesharaki-Zadeh said.
While these habits don't cover the whole list of dementia risk factors, they are a pretty solid start.This article originally appeared on HuffPost.
Also in Goodful: Therapists Are Revealing The Moments That Made Them Break Their "No Judgment" Rule, And I'm Honestly Speechless
Also in Goodful: 19 "Garbage" Modern Trends People Refuse To Partake In Despite Their Popularity
Also in Goodful: Medical Professionals Are Sharing "Mundane" Things That Actually Make So Many People Sick
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
7 hours ago
- Yahoo
Cholesterol Isn't Just About Heart Health—It May Be the Missing Link In Alzheimer's, Says New Study
"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." A new study suggests that there's a link between how well you move cholesterol to the neurons in your brain and Alzheimer's disease. This factor is connected to the APOE4 genetic variant, which significantly increases your risk of developing the disease. Here's what to know and what this means for Alzheimer's research. Alzheimer's disease sparks a cascade of changes throughout the body that lead to a slew of debilitating symptoms. But there's one surprising biological change that researchers are just starting to uncover, thanks to a new study. The study, which was published in the Journal of Lipid Research, found that people with Alzheimer's disease experience a breakdown in the ability to shuttle cholesterol to the neurons in their brain, and that this symptom is linked to a certain genetic variant called APOE4, which carries a known risk for Alzheimer's. This biological discovery could potentially pave the way for a better understanding of the disease and even future disease prevention methods. Here's what you need to know about the science so far, with input from a neurologist. Meet the expert: Clifford Segil, DO, is a neurologist at Providence Saint John's Health Center in Santa Monica, CA. What did the researchers find? For the study, researchers analyzed the cerebrospinal fluid (the biological liquid that surrounds and cushions the brain and spinal cord) from 10 patients with Alzheimer's disease and compared it to the cerebrospinal fluid of 10 people who did not have the condition. They discovered that lipoproteins (round particles made of fat and protein) in the cerebrospinal fluid of Alzheimer's patients were less effective at delivering cholesterol to neurons, or nerve cells, which are responsible for transmitting information from the brain throughout the body. What is cholesterol? Cholesterol is an essential, waxy, fat-like molecule that your body needs for good health, according to the National Heart Lung and Blood Institute (NHLBI). Cholesterol is carried around your body by two types of lipoproteins: low-density lipoproteins (a.k.a. LDL or 'bad' cholesterol) and high-density lipoproteins (a.k.a. HDL or 'good' cholesterol). High levels of LDL cholesterol can cause a buildup of fatty deposits called plaque in your arteries, raising the risk of heart attack, stroke, and other health complications, per the NHLBI. But high levels of good HDL cholesterol may lower the risk for certain health issues. Why is it important for brain function? While it has a bad rap in the health world, cholesterol is actually really important for your proper brain function. Your brain is the most cholesterol-rich organ in your body. Specifically, cholesterol helps make up cell membranes, including those in nerve cells, and plays a crucial role in your neurons' ability to "talk" to each other and transmit information. When cholesterol levels are out of balance, it can impact that transmission of essential information between nerve cells, leading to cognitive issues that are seen with neurodegenerative diseases like Alzheimer's disease. Cholesterol is also a building block for steroid hormones, which support brain function. However, that doesn't mean more cholesterol is always good for your brain. High levels of LDL cholesterol are usually considered a modifiable risk factor for ischemic stroke, or 'clogged pipes' in the brain, explains Clifford Segil, DO, a neurologist at Providence Saint John's Health Center in Santa Monica, CA. 'There is less research and understanding on the possible benefits of cholesterol found in spinal fluid including HDL, which we classically identify as the 'good cholesterol,'' Dr. Segil says. 'We know high levels of certain types of cholesterol cause strokes and we are less clear in the year 2025 about the benefits of cholesterol in brain function.' How does this link back to Alzheimer's? This particular study noted that cholesterol found in lipoproteins were different in patients with Alzheimer's disease, but Dr. Segil says that there is a 'complicated' relationship between lipids and protein in the brain. 'Some researchers continue to assign memory loss symptoms in patients with Alzheimer's due to abnormal brain protein levels and this paper noted lipid brain levels may also be abnormal,' he says. Dr. Segil points out that neurologists commonly prescribe medications called statins to lower levels of cholesterol and the risk of stroke. Lowering levels of LDL cholesterol can decrease the risk of developing certain type of dementia, including vascular dementia, he says. But it's not clear if it may do more. 'Further research will determine if lowering your cholesterol will result in lower chances of getting Alzheimer's dementia,' he says. You Might Also Like Jennifer Garner Swears By This Retinol Eye Cream These New Kicks Will Help You Smash Your Cross-Training Goals Solve the daily Crossword
Yahoo
10 hours ago
- Yahoo
Anavex Life Pre-Treatment Prevented Cognitive Impairment In Animal Model of Alzheimer's Disease, New Publication Shows
Anavex Life Sciences Corp. (NASDAQ:AVXL) reported a peer-reviewed publication in the journal Neuroscience Letters on Wednesday. The study shows that a pre-treatment with blarcamesine prevented Amyloid beta-induced memory impairment and brain oxidative injury. "This preclinical study is exciting since it clearly demonstrates a preventative effect of blarcamesine in Alzheimer's pathology and potentially might be able to prevent onset of Alzheimer's disease in healthy individuals," said Tangui Maurice, PhD, Research Director at the University of Montpellier, France and author of the placebo-controlled mice developed significant amyloid toxicity in the brains after the toxic Aβ25-35 peptide injection, in animals pre-treated with blarcamesine, significant protection was observed, with less vulnerability to Aβ25-35-induced oxidative stress and less vulnerability to develop learning and memory deficits. The mechanistic confirmation that blarcamesine particularly restores impaired autophagy through SIGMAR1 activation by acting upstream of amyloid and tau pathologies at the molecular level was previously established in vitro and in vivo. Blarcamesine studies demonstrated the effect of enhanced autophagic flux in human cells and in C. elegans, as well as increased proteostasis capacity and ability to promote autophagosome biogenesis, autophagic cargo reception, and lysosome fusion. SIGMAR1 has emerged as a key therapeutic target in the treatment of neurodegenerative disorders. Its activation enhances autophagy, facilitating the degradation of amyloid-beta precursor protein (APP) and helping to normalize Aβ production. SIGMAR1 activation supports neurogenesis, mitigates oxidative stress by reducing reactive oxygen species (ROS), suppresses neuroinflammatory responses, and alleviates Aβ-induced toxicity. It also plays a critical role in maintaining endoplasmic reticulum (ER) integrity and modulating intracellular calcium signaling. Collectively, these effects contribute to restoring cellular homeostasis, rebalancing neural function, and promoting neuroplasticity. In April, Anavex Life Sciences announced that over three years of continuous treatment with blarcamesine (ANAVEX 2-73) demonstrated significant amelioration of clinical decline, showing continued clinical and meaningful benefit for early Alzheimer's disease patients. Price Action: AVXL stock is up 1.59% at $9.59 during the premarket session at the last check on Wednesday. Read Next:Photo via Shutterstock UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? This article Anavex Life Pre-Treatment Prevented Cognitive Impairment In Animal Model of Alzheimer's Disease, New Publication Shows originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Medscape
10 hours ago
- Medscape
Beetroot Juice's Blood Pressure Secret: The Nitrate Effect
A study from the University of Exeter, Exeter, England, found that regular consumption of beetroot juice may help lower blood pressure in adults over 60 years of age. Beetroot is naturally rich in micronutrients and minerals, and its nitrate content plays a central role in this effect. Evidence has shown that poor oral health and microbial imbalances can reduce the body's ability to convert dietary nitrate into nitric oxide, a compound essential for blood pressure regulation. These findings highlight the potential cardiovascular benefits of nitrate-rich foods, such as beetroot juice. Study Details The placebo-controlled, double-blind crossover trial involved 39 participants under 30 and 36 healthy elderly individuals 60-70 years of age. Individuals from both the group consumed the nitrate-rich beetroot juice (750 mg of nitrate) daily for 2 weeks and then, after a 2-week washout period, a placebo version of the juice without nitrate. Researchers analyzed the oral microbiomes of the participants through gene sequencing before and after a 2-week regimen of twice-daily antiseptic mouthwash use. Key Findings At baseline, the microbiome did not differ between younger and older adults. After consuming nitrate-rich juice, individuals from both groups showed changes, but the effects differed. In older adults, harmful bacteria such as Prevotella decreased, whereas beneficial bacteria such as Neisseria increased. This shift was associated with higher nitrite levels. Older participants had a slightly higher average blood pressure (126/80 mm Hg). With nitrate-rich juice, their blood pressure dropped by approximately 7 mm Hg. No effect was seen with placebo juice or in younger adults who already had normal blood pressure. These findings suggest that nitrate lowers blood pressure by reducing harmful oral bacteria and improving the conversion of nitrate to nitric oxide. This mechanism may be particularly important in older adults as natural nitric oxide production declines with age. Foods rich in nitrate, such as spinach, arugula, fennel, celery, and kale, may provide similar benefits. Larger studies are needed to confirm these effects in older adults. This story was translated from Coliquio.
